Domainex receives funding from Takeda Research Investment
Existing shareholders Longbow and The Capital Fund also contribute alongside this endorsement from a corporate pharmaceutical investor
18-Feb-2010 -
Domainex has secured further financing to develop its Combinatorial Domain Hunting (CDH) technology, and to advance its internal pipeline of oncology targets. The patented CDH technology puts Domainex in a unique position to clone and express challenging protein drug targets. This funding will ...
cooperations
enzymes
oncology
+1